BAXTER HEALTHCARE CORPORATION PRISMAFLEX SEPXIRIS150 DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
|
Back to Search Results |
|
Catalog Number 955617 |
Device Problems
Fluid Leak (1250); Improper or Incorrect Procedure or Method (2017)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/25/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
Prismaflex sepxiris set 150 (jp) is similar to prismaflex st150 set, prismaflex st150 set ckt, and prismaflex st150 set c.
Prismaflex st150 set, prismaflex st150 set ckt, and prismaflex st150 set c have been temporarily approved for use in the us under emergency use authorization (b)(4) to deliver crrt to treat patients in an acute care environment during the covid-19 pandemic.
Should additional relevant information become available, a supplemental report will be submitted.
|
|
Event Description
|
It was reported that during treatment with a prismaflex sepxiris set 150, an external blood leak from the return injection port located upstream of the deaeration chamber occurred.
An anticoagulant (nafamostat mesilate/ futhan), was administered via the injection port using a 20g needle and a non baxter syringe pump.
After twenty (20) hours of treatment, an obstruction alarm was generated by the syringe pump and the operator removed the 20g needle to replace it.
However, blood was observed to leak out from the hole where the needle had been inserted.
A new 20g needled was inserted in the same hole and the blood leak was stopped.
There was no patient injury or medical intervention associated with this event.
No additional information is available.
|
|
Search Alerts/Recalls
|
|
|